Randomized, Double-blind, Placebo-controlled Trial of the Efficacy and Safety of Tianeptine in the Treatment of Covid Fog Symptoms in Patients After COVID-19.
Randomized, Double-blind, Placebo-controlled Trial of the Efficacy and Safety of Tianeptine in the Treatment of Covid Fog Symptoms in Patients After COVID-19.
Recruiting · NCT06012552 · Registry updated 2023-08-25Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Randomized, Double-blind, Placebo-controlled Trial of the Efficacy and Safety of Tianeptine in the Treatment of Covid Fog Symptoms in Patients After COVID-19. | COVID-19, Confusion, Coronaviridae Infections, Fatigue, Headache, Infections, Memory Disorders, Mental Fatigue, Neurobehavioral Manifestations, Neurologic Manifestations, Nidovirales infectious disease, Orthocoronavirinae infectious disease, Pain, Pathological Conditions, Signs and Symptoms, RNA Virus Infections, Signs and Symptoms, lung disorder, nervous system disorder, pneumonia, respiratory system disorder, respiratory tract infectious disorder, viral infectious disease, viral pneumonia | Recruiting | Phase 2 | 2023-08-25 | NCT06012552 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| ABM Industries | 1 |
| Military Institute od Medicine National Research Institute | 9 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Anna Klimkiewicz | Warsaw | Poland | 1 |